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The Role of Chemokines Minireview
in Regulating Cell Migration
during Humoral Immune Responses
place in bone marrow and in the thymus, in a microenvi-
ronment containing stromal cells of hematopoietic and
nonhematopoietic origin. Hematopoietic progenitors and
precursors of the different cell lineages communicate
with stromal cells by chemoattraction, adhesion, and
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Switzerland cytokine secretion, which are necessary for the produc-
tion of mature T cells, B cells, and APC. It is thought
that HSC (Figure 1, cell type 1) divide asymmetrically to
renew themselves, whereas the other cell in a divisionThree major types of hematopoietic cells cooperate in
further differentiates and migrates to a new microenvi-the recognition of antigens in humoral adaptive immune
ronment, perhaps with a different stroma. These latterresponses: T lymphocytes, B lymphocytes, and antigen-
cells change their hematopoietic potential, first becom-presenting cells (APC). All three types of cells originate
ing erythroid-myeloid-lymphoid progenitors, which thenfrom pluripotent hematopoietic stem cells (HSC), are
made in the primary lymphoid organs (bone marrow and
thymus), and are used for immune responses in second-
ary lymphoid organs (spleen, lymph nodes, and the gut-
associated lymphoid tissues), and in nonlymphoid tis-
sues. The essence of a properly functioning immune
system is the high degree of cell motility during cell
maturation and immune responses.
Cell migration is controlled by multistep processes that
include chemoattraction, cell±cell adhesion and, where
needed, transmigration through cell layers (Springer,
1994; Butcher et al., 1999). In this review we will consider
the trafficking of cells cooperating in the development
of the immune system and in a humoral immune re-
sponse. We will focus our attention on the role(s) of
chemokines and their receptors during these processes.
The importance of chemokines (which are classified on
the basis of the number and spacing of NH2-terminal
cysteins into C, CC, CXC, and CX3C chemokines) and
their receptors in the microanatomical structuring of
lymphoid organs has been established (for a recent re-
view see Zlotnik et al., 1999), but the role of each chemo-
kine in regulating immune cell development and immune
responses is far from understood.
Several chemokines and their receptors are candi-
dates for controlling the migration of lymphocytes within
primary lymphoid organs, from primary to secondary
lymphoid organs and, during a humoral immune re-
sponse, within and between secondary lymphoid or-
Figure 1. A Roadmap of Lymphocyte Traffic in the Immune Systemgans. Most of them have only been characterized by
Travel begins at the stage of HSC (1) in the bone marrow and pro-their expression and by chemotactic activities measured
ceeds through myeloid-lymphoid (2) to lymphoid (3) progenitors. Atin vitro. For only a few has it been possible to determine
this point two routes can be taken: either B lineage development
their function in vivo either by naturally occurring defects through preB-I (4), large preB-II (5), small preB-II (6), and immature
or by targeted inactivation of the chemokine or chemo- B cell (7) stages, and from there out into venous blood, the heart,
and arterial blood (red lines and arrows; B-route, yellow marks), orkine receptor genes. This lack of functional insight is
travel to the thymus (T route, green marks) via blood where T celllikely to be a consequence of redundancy in the system.
development through double-negative (8), preT cell receptor±One chemokine can have more than one receptor, one
positive (9), double CD41CD81 (10), and single CD41 or CD81 thymo-receptor can recognize more than one chemokine, one
cyte (11) stages, takes place before the cells enter into the blood.
cell can produce more than one chemokine, and several T and B cells enter and leave the spleen, peripheral tissues, regional
different types of cells can produce either the same lymph nodes and postcapillary venules (as are HEV) through blood.
T and B cells enter the areas in lymph nodes through HEV. Thesechemokine or the same chemokine receptor.
areas are drained by efferent lymphatics (blue lines and arrows).The Generation of Cells Involved
The lymphatics feed back into the lymph nodes and collect in thein a Humoral Response
ductus thoracicus. At the vena subclavia lymphocytes traverse fromThe travels of a cell destined to become one of the
lymph back into venous blood and begin their recirculation. The
hematopoietic participants of an immune response orig- area marked by pink bars shows the sites where the chemokines
inate at the inner side of the bone, near the endosteum and their receptors described in more detail in the text are proposed
to control the traffic of cells.(Figure 1). Cell development from pluripotent HSC takes
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differentiate to become myeloid-lymphoid progenitors myeloid and B-lymphoid progenitor and precursor com-
partments with normal numbers of cells is abolished(Figure 1, cell type 2). After differentiation of the myeloid-
lymphoid cells to the myeloid-lineage pathway, the re- when CXCR4 is defective. Instead, these progenitors
and precursors appear in increased numbers in bloodsulting monocytes enter the venous blood, move to arte-
rial blood in the heart and are distributed into lymphoid indicating that proper retention in the primary organ,
but not the production of these cells, is defective. Thus,and nonlymphoid tissues where they can differentiate
to APC of either macrophage or dendritic cell (DC) phe- SDF-1 and CXCR4 interaction appear to be monogamic,
since their loss cannot be compensated by alternativenotype (see below).
The lymphoid progenitors (Figure 1, cell type 3) may chemokines and their receptors.
Although SDF-1 is expressed in the thymus and theremain in the bone marrow and proceed along the
B-lymphoid differentiation pathway (Figure 1, B route), early CD41CD81 thymocytes are attracted to it (Camp-
bell et al., 1999), T lymphopoiesis in SDF-1- and CXCR4-or travel through blood into the thymus, and enter the
cortical regions to differentiate along the T lineage path- deficient mice is normal. This could be because the
chemokine TECK is probably active on these early thy-way (Figure 1, T route). In bone marrow, commitment
to B lineage development results in stepwise V(D)J re- mocytes, as it is expressed by dendritic cells in the
thymus and attracts the same early thymocytes. Thearrangements in the immunoglobulin (Ig) H and IgL chain
loci. Those cells with productive IgH and L chain gene transitional state from CD41CD81 to CD41 or CD81 thy-
mocytes and the further migration out of the thymusrearrangements express IgM on their surface (sIgM1),
if the H and L chains can pair with each other. Immature could be controlled by MDC/ABCD-1, recognized by
the CCR4 receptor, and by SLC and MIP-3b/ELC, bothsIgM1 B cells with high avidity for autoantigens in the
bone marrow are arrested in their development and die recognized by CCR7, since these chemokines attract
the CD41 and CD81 thymocytes of the thymic medulla,in situ (ªnegative selectionº), while the nonautoreactive
immature B cells can exit the bone marrow via the ve- but not the immature CD41CD81 thymocytes of the thy-
mic cortex (Campbell et al., 1999).nous sinuses (Melchers and Rolink, 1999; and refer-
ences therein). As with monocytes, the immature sIgM1 The Population of Secondary Lymphoid Organs
with LymphocytesB cells move to arterial blood in the heart.
In the thymus, stepwise V(D)J rearrangements at the From arterial blood immature, antigen-inexperienced
sIgM1 B cells enter the spleen via the central arteryT cell receptor (TCR) a, b, g, and d gene loci lead to
the generation of a/b TCR1 and g/d TCR1 thymocytes and the marginal sinuses (Figure 1), and first become
localized in the periarteriolar lymphoid sheath (PALS)through a sequence of cellular stages that for the a/b
TCR-expressing cells are strikingly similar to the corre- surrounding the central artery where they may be nega-
tively selected against autoantigens that were not pres-sponding development of sIgM1 B cells in the bone
marrow (Figure 1). a/b TCR-expressing thymocytes ex- ent in bone marrow. They then mature to sIgM1sIgD1
B cells and form primary follicles in the follicular zone.pressing both CD4 and CD8 coreceptors on the same
cell are confronted with processed antigen (in the form Mature, but not immature B cells next enter the lymph
nodes via arterioles immigrating from the blood streamof peptides) on the major histocompatibility complex
(MHC) class I or II molecules on specialized APC. CD41 by transmigration through high endothelial venules
(HEV). In the lymph node, mature B cells localize in theCD81 thymocytes expressing TCR with high avidity for
MHC class I or II/autoantigen peptide complexes un- cortical areas surrounding the paracortex. CD41 and
CD81 T cells also enter the spleen and the lymph nodesdergo negative selection. Those cells displaying a/b
TCR with intermediate affinities for either MHC class I via arterial blood through specialized entry sites, the
marginal sinuses, or HEV, respectively. They migrate inor class II peptide complexes downregulate the expres-
sion of either CD4 or CD8 molecules, mature to CD4 or spleen to the PALS, and in lymph node to the paracortex,
and remain in these areas until initiation of an immuneCD8 single positive cells (ªpositive selectionº), migrate
to the medulla, and leave the thymus via venous blood response.
The migration of resting T and B cells into secondaryto move to arterial blood in the heart.
Myeloid and B-lymphoid development occurs in fetal lymphoid organs can be expected to be controlled at
the entry sites (Figure 2). So far, SLC produced by HEVliver during embryonic life, then shifts to the bone mar-
row after birth. This feature has allowed Ma and col- is one chemokine that could perform this function since
both resting T and B cells express the correspondingleagues (1999) to study the effects of the targeted dis-
ruption of the gene encoding the SDF-1 chemokine receptor CCR7. However, in plt mice that lack SLC (and
may have other defects), only T cells fail to populate thereceptor CXCR4 in fetal liver hematopoiesis (before the
mutant mice die perinatally). The CXC chemokine SDF-1 T cell±rich PALS and paracortex, whereas B cell±rich
follicles and cortical areas appear normally filled (Gunnis highly expressed by fetal liver and bone marrow stro-
mal cells whereas CXCR4 is expressed on hematopoi- et al., 1999; and references therein). FoÈ rster and col-
leagues have recently shown that the distribution of Tetic progenitors, B cell progenitors, mature T and B
lymphocytes, and monocytes. It has been shown that and B cells in the secondary lymphoid organs is dis-
turbed in CCR7-deficient mice (FoÈ rster et al., 1999), suchCXCR4-deficient and SDF-1-deficient mice have similar
defects in neuron migration, organ vascularization, and that in spleen and lymph nodes the T and B cell±rich
areas do not form properly. Instead, both T and B cellshematopoiesis (see references in Ma et al., 1999). More-
over, B lymphopoiesis is severely reduced in fetal liver are found in lower numbers in the splenic PALS and the
paracortex of lymph nodes, while they appear in higherand bone marrow, and myelopoiesis is decreased in
fetal liver and virtually absent in bone marrow. Ma and numbers in the blood. Many T cells remain in the mar-
ginal sinus in the spleen, while B cells migrate to the Tcolleagues (1999) have shown that proper filling of the
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secondary lymphoid organs normally (Ma et al., 1999).
Hence, entry might be controlled for T cells, but not
for B cells by SLC/CCR7 interactions alone, whereas
homing to the appropriate B cell±rich areas might be
regulated through both SLC/CCR7 and SDF-1/CXCR4
interactions.
After B and T cells have traversed the HEV, and B
cells have settled in the cortical areas and T cells have
settled in the paracortical areas, they leave the node via
efferent lymphatics and join the venous blood again in
the vena subclavia (Figure 1). As antigen-experienced
cells in peripheral tissues, memory T and B cells can
also enter the lymph node via the afferent lymphatics.
Cellular Traffic during a Humoral Immune Response
Once APC are in the tissues, and resting, mature T and B
cells are in their proper areas in the secondary lymphoid
organs, the major participants in an immune response
are in place to react to the invasion of foreign antigen.
However, they remain segregated until they need to
cooperate in a humoral response.
An immune response to a foreign invader often begins
in the epithelia of skin and mucous membranes with
which we face the outside world. It appears that native
antigen must reach two types of primary target cells: a
resting DC and a resting B cell. Binding and uptake of
antigen activates both cells, perhaps without the help
of other cells. Activation of DC induces the production of
Figure 2. Model for the Trafficking and Control of an Antigen-Spe- proinflammatory chemokines that recruit other myeloid
cific, Helper T Cell±Dependent Response of B Cells in the B Cell± cells and T cells into the area of antigen invasion. At the
and T Cell±Rich Zones of a Secondary Lymphoid Organ
same time, locally released inflammatory stimuli (e.g.,
First, resting T and B cells enter the lymphoid organ through HEV
IL-1, TNFa, LPS, double-stranded RNA) induce matura-producing the chemokine SLC (step 1) and home to stromal cells
tion of immature DC to mature DC. In this process DCproducing SLC and SDF-1 (step 2). Native antigen (blue arrows)
switch their chemokine receptor profile and upregulateenters through the epithelia, is taken up by immature DC and pro-
cessed into peptides (blue bars). The DC are admitted to the organ the expression of CCR7 (Sallusto et al., 1998). CCR7-
via HEV-producing SLC (step 1) and migrate to the T-rich areas, expressing DC enter the circulation via blood and lymph
attracted by ELC produced by mature DC (DC*) (step 3) where they and arrive at the entry sites (the HEV) in lymph nodes,
display the peptides bound in MHC complexes on the surface to and are admitted to the lymphoid organs in an SLC-
resting T cells (To). The T cells are activated and polarized to become dependent process (Figure 2, step 1; Gunn et al., 1998,either TH1 or TH2 if their TCR is specific for the complexes (step 4).
1999). ELC produced by previously recruited mature DCMDC (ABCD-1) and TARC (ABCD-2) produced by DC attract the
then attract the newly arrived DC into the same T cell±DCactivated T cells (T*) and keep them in close contact (step 5). In the
meantime native antigen has activated resting B cells (Bo, step 6). interaction regions in and near the PALS (Figure 2,
The activated B cells (B*) produce LTa, LTb, and TNFa to activate step 3).
and mature follicular dendritic cells (FDC). Signaling through LTb-R In the T cell±rich areas (PALS, paracortex) the mature
in the FDC induces secretion of BLC, which attracts activated B antigen-presenting DC expressing cell surface antigenic
cells expressing CXCR5 (step 8). Activated B cells also produce
peptide±MHC complexes activate T cells expressingMDC (ABCD-1) and TARC (ABCD-2) to attract the activated TH cells
cognate TCR (Figure 2, step 4). FoÈ rster and colleagues(step 7). Once attracted the antigen-specific TH cells cooperate in
(1999) have found that in CCR7-deficient mice DC areclose contact with the antigen-specific B cells in the areas defined
by stromal cells and FDC to generate a GC, from which plasma cells unable to migrate to secondary lymphoid organs and
and memory B cells emigrate (step 9). into the T zones. Hence, primary responses of T cells,
both to T cell±dependent antigens and in delayed-type
cell±rich areas, and then to the B cell±rich areas, but hypersensitivity reactions, are severely reduced or ab-
are not retained as (im)mature B cells in the PALS. The sent. The T cell response takes longer to reach the peak
attained in wild-type mice, as if fewer T cells could beobserved defects could be interpreted to indicate that
CCR7 expression on T and B cells is required first to initially activated and recruited into the response. How-
ever, T cell±dependent responses to antigen become nor-recognize SLC produced by HEV to allow entry from
blood into secondary lymphoid organs (Figure 2, step mal with time and appear to be ongoing, as if (T cell±
dependent?) downmodulation of humoral responses1). CCR7 is then required again to recognize SLC pro-
duced by stromal cells to allow proper positioning of were impaired.
After activation of T cells, helper T cells (TH) develop.resting T and B cells into their appropriate areas (Figure
2, step 2). SDF-1, produced by stromal cells in second- Since the activated DC secrete MDC (ABCD-1) and
TARC (ABCD-2), these chemokines might be responsi-ary lymphoid organs, and recognized by CXCR4, ex-
pressed on resting T and B cells, may also play a role in ble for keeping the activated TH cells attracted to the DC
presenting MHC-peptide complexes, so that continuoustheir proper localization. However, SDF-1- and CXCR4-
deficient mice organize their T and B cell±rich areas of DC±T cell interaction maintains the stimulation of the TH
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cells (Figure 2, step 5; Schaniel et al., 1999). This sets response a GC has formed. Memory B cells and plasma
the stage for a T helper cell±dependent B cell response, cells generated in the GC are thought to emigrate, either
known to be effective in hypermutation and Ig class to sites of inflammation or to the bone marrow (via lymph
switching. It should be stressed that the actions of MDC and blood) where they can be localized long after the
(ABCD-1) and TARC (ABCD-2) have so far only been response to foreign antigen has subsided.
demonstrated in vitro, but not in vivo. This review has focused only on one aspect of the
In parallel, native antigen enters the B cell±rich areas, molecular and cellular interactions of a humoral immune
binds to surface Ig on resting B cells and activates them response: chemokines and their receptors. Cell adhe-
(Figure 2, step 6). This may occur in combination with the sion is controlled by selectins, transmigration mediated
costimulatory action of inflammatory molecules, such as by integrins, cell±cell cooperation by costimulatory mol-
LPS and double-stranded nucleic acids, often without ecules and by cytokines. A much more sophisticated
the help of T cells and outside the follicular region. Once program of cellular changes during this response is al-
the B cells are stimulated, all the major participants ready partially known, but has not been considered here:
in the humoral immune response have been activated e.g., changes during differentiation from immature to
by foreign antigen, but B cells will either need to come mature to memory T and B cells, B1-type and conven-
together with the DC±T cell conjugates or recruit acti- tional B cell responses, and the involvement of other
vated TH cells. It is not clear whether initially the B cells hematopoietic and nonhematopoietic cells. However, it
migrate to the DC±T cell conjugates, either within the T should be clear from this simplified description of the
cell±rich areas or at the borders to the B cell areas topology of a humoral response that cell migrations are
(Figure 2, step 7 opposite direction), or whether the an indispensable requirement for the proper execution
activated T cells migrate to the B cells (Figure 2, step of this response, and that many more modes of at-
7). The latter direction of migration might be imposed traction are still to be discovered.
by MDC (ABCD-1) and TARC (ABCD-2) which are also
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